1. Market Research
  2. > Healthcare Market Trends
  3. > Oncology Pathways in the US – Friend or Foe for Pharma?

Oncology Pathways in the US – Friend or Foe for Pharma?

  • July 2015
  • -
  • Datamonitor Healthcare
  • -
  • 59 pages

Summary

Table of Contents

Search Inside

The costs of treating cancer in the US are spiraling upward, and payers have taken notice. The growing focus on value and quality has driven greater use of clinical pathways: structured, standardized, evidence-based patient management plans that typically favor the most effective, least toxic, and lowest cost treatment options. Providers implement pathways to align treatment with best practices, and payers have used pathways in several models that tie incentives to oncologists’ adherence to on-pathway treatment.

Results from recent research with US payers suggest that the trend is toward a growing market for pathways, with a significant proportion of payers expecting the use of oncology pathway programs to increase. Given the potential of clinical pathways to open up markets to oncology medicines – or to erect significant barriers to their use – the pharmaceutical industry needs to carve out a more substantial role in the development or implementation of pathway-based payment programs, while bearing in mind that pathways are only one of the many tools that payers are using as they shift from paying for volume to reimbursing value.

This report addresses the following questions:
- Who is developing and using oncology clinical pathways?
- What is the role of oncology pathways in the evolving oncology cost management strategies?
- What impact have oncology pathways had on the oncology drug use so far?
- What are the drivers and resistors of wider use of oncology pathways from the perspective of different stakeholders?
- What key developments in the US reimbursement landscape are likely to influence the use of oncology pathways in the future and what will their impact will be?
- What strategies do pharmaceutical companies need to implement to mitigate the potential negative impact of oncology pathways on their oncology products or maximize opportunities?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021

Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Asia-Pacific Bronchoscopes Market Outlook to 2023

Asia-Pacific Bronchoscopes Market Outlook to 2023

  • $ 5995
  • Industry report
  • April 2017
  • by GlobalData

Asia-Pacific Bronchoscopes Market Outlook to 2023 Summary GlobalData’s new report, "Asia-Pacific Bronchoscopes Market Outlook to 2023", provides key market data on the Asia-Pacific Bronchoscopes market. ...


Download Unlimited Documents from Trusted Public Sources

Hospital Industry in the US

  • April 2017
    12 pages
  • Hospital  

  • United States  

View report >

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Nutrition Markets in the US - Forecast

  • April 2017
    4 pages
  • Nutrition  

  • United States  

View report >

Related Market Segments :

Health Care Provider
Hospital
Oncology
Cancer

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.